Abstract:Importance Cognitive impairment contributes significantly to clinical outcome and level of function in individuals with psychotic disorders. These impairments are present already at psychosis onset at a group level; however, the question of heterogeneity in cognitive function among patients has not been systematically investigated. Objective To provide an updated quantification of cognitive impairment at psychosis onset before patients receive potentially confounding antipsychotic treatment, and to investigate variability in cognitive function compared with healthy controls. Data Sources In this systematic review and meta-analysis, PubMed articles were searched up to September 15, 2022. Study Selection Original studies reporting data on cognitive function in antipsychotic drug–naive patients with first-episode psychosis (FEP) were included. Data Extraction and Synthesis Data were independently extracted by 2 researchers. Cognitive tasks were clustered according to 6 domains of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery and the domain of executive function. Random-effects model meta-analyses of mean differences and coefficient of variation ratios (CVRs) were performed, as well as meta-regressions, assessment of study quality, and publication bias. Main Outcomes and Measures The main outcome measure was Hedges g for mean differences in cognition and CVR for within-group variability. Results Fifty studies were included in the analysis with a total of 2625 individuals with FEP (mean [SD] age, 25.2 [3.6] years, 60% male; 40% female) and 2917 healthy controls (mean [SD] age, 26.0 [4.6]; 55% male; 45% female). In all cognitive domains, the FEP group displayed significant impairment compared with controls (speed of processing: Hedges g = −1.16; 95% CI, −1.35 to −0.98; verbal learning: Hedges g = −1.08; 95% CI, −1.28 to −0.88; visual learning: Hedges g = −1.05; 95% CI, −1.27 to −0.82; working memory: Hedges g = −1.04; 95% CI, −1.35 to −0.73; attention: Hedges g = −1.03; 95% CI, −1.24 to −0.82; reasoning/problem solving: Hedges g = −0.90; 95% CI, −1.12 to −0.68; executive function: Hedges g = −0.88; 95% CI, −1.07 to −0.69). Individuals with FEP also exhibited a larger variability across all domains (CVR range, 1.34-1.92). Conclusions and Relevance Results of this systematic review and meta-analysis identified cognitive impairment in FEP before the initiation of antipsychotic treatment, with large effect sizes. The high variability within the FEP group suggests the need to identify those individuals with more severe cognitive problems who risk worse outcomes and could benefit the most from cognitive remediation.

Trajectories of Cognitive Function in First-Episode Psychosis: Associations to Clinical Outcomes and Biological Markers

Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study

Cognitive Function and Variability in Antipsychotic Drug–Naive Patients With First-Episode Psychosis

The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies

Antipsychotic Treatment Effects on Progression of Brain Pathomorphology in First Episode Schizophrenia

Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study

Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First Episode

Neurocognitive profiles in the prodrome to psychosis in NAPLS-1

Longitudinal changes in cognitive function in early psychosis: a meta-analysis with the MATRICS consensus cognitive battery (MCCB)

Cognitive Deficits in Subjects at Risk for Psychosis, First-Episode and Chronic Schizophrenia Patients.

Rethinking the course of psychotic disorders: modelling long-term symptom trajectories

Subtyping First-Episode Psychosis based on Longitudinal Symptom Trajectories Using Machine Learning

Neurocognitive functioning and emotional recognition in first-episode psychosis: protocol for a follow- up study

The relationship between blood-brain barrier dysfunction and neurocognitive impairments in first-episode psychosis: findings from a retrospective chart analysis

Trajectories of behavior and social cognition in behavioral variant frontotemporal dementia and primary psychiatric disorders: A call for better operationalization of socioemotional changes

Cognitive Function in First-Episode Adolescent-Onset Schizophrenia Before and after Treatment

SU40. Cognitive Function Deficits in High-Risk, First-Episode, and Chronic Schizophrenia

Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study

Trajectories of Social Function in Patients with First-Episode Schizophrenia: Analysis of Data from a 10-Year Follow-Up Study.

Associations Between Age and Neurocognition in Individuals at Clinical High Risk and First-Episode Psychosis.

Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study